Data from a Chronic Renal Insufficiency Cohort study show that the first alteration observed is elevated serum FGF23, followed be decreased serum 1,25D, elevated serum PTH, and eventually elevated serum phosphate. This evidence concerns the gene FGF23 and chronic kidney disease.